AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Lukovor Injection

Prescription Icon
Prescription Required

Marketer

Aureate Healthcare Pvt Ltd

Salt Composition

Calcium Leucovorin (10mg/ml)

Overview Lukovor Injection

Leucovorin injection counteracts the adverse effects of methotrexate, a cancer treatment medication, and serves as an antidote for methotrexate overdose. Administered intravenously at a slow rate under medical supervision, the dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's instructions, as incorrect usage or excessive dosage can lead to severe complications. Common injection site reactions, including pain, swelling, and redness, may occur; report any concerning symptoms to your doctor, as mitigation strategies may be available. Regular blood tests to monitor blood cell counts and serum methotrexate levels are necessary. Prior to treatment, inform your physician of any pre-existing conditions, such as seizures, liver or kidney impairment, or current medication use, especially anti-infectives. Interactions with other medications are possible, so disclose all medications, particularly those like phenytoin used to manage seizures. Before commencing treatment, pregnant or breastfeeding individuals should consult their doctor regarding the safety of leucovorin.

Primary Ingredients of Lukovor Injection

No text was provided to rewrite.

Uses of Lukovor Injection

Mitigating Methotrexate's Adverse Reactions

Major Benefits of Lukovor Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Lukovor Injection:

  • Injection site reactions (pain, swelling, redness)

How to use Lukovor Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Lukovor Injection works:

Injected Lukovor, a vitamin B derivative, safeguards healthy cells from methotrexate's (a cancer medication) toxicity, enabling selective cancer cell destruction.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Lukovor Injection presents unknown safety implications. Physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Lukovor Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Lukovor Injection with breastfeeding is absent. Seek your physician's advice.

DrivingDrivingSAFE

Driving ability is typically unaffected by Lukovor Injection.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding Lukovor Injection's application in individuals with renal impairment. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Lukovor Injection's efficacy and safety in individuals with hepatic impairment. Physician consultation is recommended.

What if you forget to take Lukovor Injection :

Should you forget a Lukovor Injection, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Lukovor Injection

LabelValue
Type of Compound Amino acid-based glutamate compounds
Potential for Dependence None.
Treatment Category Hematological
Mechanism of Action Drugs protecting cells from damage: methotrexate.

FAQs on Lukovor Injection

Leucovorin injection counteracts the adverse effects of methotrexate, a cancer chemotherapy drug, specifically when methotrexate is employed in cancer treatment. This injection also serves as a treatment for accidental methotrexate or comparable drug overdoses. Furthermore, it's indicated for megaloblastic anemia stemming from folic acid deficiency, particularly in situations where oral administration is impractical.
Reduced red blood cell (RBC) count, resulting in insufficient oxygen delivery to bodily tissues and organs, defines anemia. Megaloblastic anemia, a specific type of anemia, is marked by abnormally large RBCs and a diminished RBC count. This condition typically stems from a deficiency in either vitamin B12 or folic acid. What is the typical onset of action for Lukovor Injection?
The effects of Lukovor Injection become noticeable within five minutes of injection. This timeframe, however, is subject to individual variation based on factors such as the administered dose and the patient's unique physiological response.
To establish the appropriate Lukovor Injection dosage and treatment length, your physician will order blood tests to measure serum methotrexate levels (particularly if you're receiving methotrexate chemotherapy or have experienced an overdose). A complete blood count will also be conducted to track red blood cell counts (especially if megaloblastic anemia is a concern). Finally, your calcium levels will be monitored to mitigate the risk of hypercalcemia, given the calcium content of Lukovor Injection.
Sustaining adult urine production exceeding 2,500 mL daily through increased oral or intravenous hydration twelve hours prior to and thirty-six hours following methotrexate infusion cessation. Urine alkalinization (promoting drug elimination) should be monitored, ensuring a urinary pH above 7.0 pre-infusion. Substances potentially increasing urinary acidity should be omitted throughout treatment. Post-infusion methotrexate blood levels must be assessed at 24, 48, and 72 hours minimum.
Lukovor Injection
242
MRP 295
17% off